Latest News

Lentigines: Study Finds Less PIH With Modified Laser Treatment


 

FROM ASLMS 2024

A Lower-Cost Option

This study showed that the 532-nm picosecond laser with fractional beam MLA is a useful option for patients with darker skin types, Kelly Stankiewicz, MD, a dermatologist who practices in Park City, Utah, and moderated the session where these results were presented, told this news organization.

“The most challenging thing about treating lentigines in darker skin types is preventing potential side effects, mainly dyspigmentation,” she said after the meeting. “These side effects are, for the most part, temporary, but they can take 6-18 months to resolve, so it’s important to prevent them in the first place.”

She noted that the 532-nm and 1064-nm wavelengths are the most commonly available for picosecond lasers and that they’re easier to produce and less expensive. “There are picosecond lasers with middle wavelengths in the red light to near-infrared range (650-785 nm) that are better for darker skin types because they are more gentle yet still effective at targeting pigment, but these lasers are more expensive and less widely available,” Dr. Stankiewicz said.

“The microlens array, used in this study with the 532-nm wavelength, is an inexpensive piece that fits at the end of the laser,” she added. “So, to have an option that turns a 532-nm laser into a safer device for the treatment of lentigines in darker skin types is very helpful.”

Dr. Manuskiatti and Dr. Stankiewicz had no relevant disclosures to report.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Rosemary, Part 2
MDedge Dermatology
Formulation of Sclerotherapy Agent Found Useful for Submental Fat Reduction
MDedge Dermatology
Expert Highlights Emerging Trends in Neuromodulators
MDedge Dermatology
New Tool Helps Clinicians Detect Zoom Dysmorphia in Virtual Settings
MDedge Dermatology
CDC Investigating Adverse Events Related to Counterfeit, Mishandled Botulinum Toxin
MDedge Dermatology
Association Calls For Increased Oversight in Response to Reports of Possibly Counterfeit Botulinum Toxin
MDedge Dermatology
Survey Finds Mental Health Issues Increased After Cosmetic Procedure Complications
MDedge Dermatology
Consensus Statement Aims to Guide Use of Low-Dose Oral Minoxidil for Hair Loss
MDedge Dermatology
PCOS: Laser, Light Therapy Helpful for Hirsutism
MDedge Dermatology
Botulinum Toxin, Dermal Fillers Safe in Skin of Color Patients, Review Finds
MDedge Dermatology